Jeffrey Baxter, MD
Assistant Professor of Family Medicine and Community Health
Medical Director, Spectrum Health Systems Outpatient Addiction Treatment Programs
Medical Director, Community Health Link Adult and Adolescent Detoxification Units
Co-Investigator, UMASS Center for Health Policy and Research
MD 1996 Washington University School of Medicine, St. Louis, MO
BA 1991 University of Rochester, Rochester, NY
Family Medicine: University of Massachusetts Medical Center, 7/1996-6/1999
Chief Resident, 7/1998-6/1999
Addiction Medicine: Boston University Medical Center, 7/02-6/03
American Board of Family Practice, 1999, re-certification 2006
American Board of Addiction Medicine, 2009
American Society of Addiction Medicine (ASAM)
Association for Medical Education and Research in Substance Abuse (AMERSA)
Society of Teachers of Family Medicine (STFM)
Please refer to Dr. Baxter's complete curriculum vitae.
Baxter JD, Clark RE, Samnaliev M, Leung GY, Hashemi L. Factors Associated with Medicaid Patients’ Access to Buprenorphine Treatment. J Subst Abuse Treat. 2011 Jul;41(1):88-96.
Clark RE, Samnaliev M, Baxter JD, Leung GY Should Medicaid programs ration opioid addiction treatment with buprenorphine? Health Affairs, in press.
Weir S, Posner HE, Zhang J, Willis G, Baxter JD, Clark RE. Predictors of Prenatal and Postpartum Care Adequacy in a Medicaid Managed Care Population. Women’s Health Issues, in press.
Baxter, Jeffrey D. Clinical Management I: Buprenorphine Treatment in Office-Based Settings. In Handbook of Office-Based Buprenorphine Treatment of Opioid Dependence, Renner JA and Levounis P, Eds. American Psychiatric Publishing, 2011.
Clark RE. Weir S. Ouellette RA. Zhang J. Baxter JD; Beyond health plans: behavioral health disorders and quality of diabetes and asthma care for Medicaid beneficiaries; Medical Care. 47(5):545-52, 2009 May.
Samnaliev, M., Baxter, J.D., Clark, R.E. Comparative Evaluation of Two Asthma Care Quality Measures Among Medicaid Beneficiaries. Chest, 135(5), 1193-1196, 2009.
Clark, R.E. and Baxter, J.D.; Buprenorphine Treatment for Opioid Dependence. Buprenorphine Knowledge Asset, Web site created by the Robert Wood Johnson Foundation’s Substance Abuse Policy Research Program; March 2009. http://www.saprp.org/KnowledgeAssets/pdf/Buprenorphine_PolicyBriefReport.pdf
Baxter J, Samnaliev M, Clark R. The Quality of Asthma Care Among Adults with Substance-Related Disorders and Adults with Mental Illness, Psychiatric Services 60:43-49,2009.
Baxter J, Samnaliev M, Clark R. Patterns of Health Care Utilization for Asthma Treatment in Adults with Substance Use Disorders, Journal of Addiction Medicine, Volume 2, Number 2, June 2008.
Renner J, Baxter J, and Ciraulo D. Depression and Substance Abuse in The Treatment of Depression, R Schrader Ed., 2004
Jeffrey Baxter, MD is an assistant professor in the Department of Family Medicine at the University of Massachusetts Medical School. He is board certified in Family Medicine and Addiction Medicine and is the medical director for a network of methadone maintenance programs and adult and adolescent detoxification centers in central Massachusetts.
Dr. Baxter’s areas of clinical and educational specialty include the treatment of opiate dependence and the interface between chronic pain and addiction. He is the course director for the pain management course for third year medical students a mentor with SAMHSA funded Physician Clinical Support Service (PCSS). He is also working with the NIDA Centers of Excellence in Physician Information Program (NIDA-CoE) developing curricular materials to educate medical providers in the safer use of opioid medications in the treatment of pain.
Dr. Baxter has been a co-investigator with the UMASS Center for Health Policy and Research for the last 6 years. His research interests include the quality of medical care for patients with substance use disorders and the quality of buprenorphine treatment for opioid dependence in Medicaid populations.
UMASS Medical School 333 South St, 13E650, Shrewsbury, MA 01545